The Oncology Institute, Inc. (TOI) financial statements and ratios from SEC XBRL: revenue $0.6B (TTM), net margin -12.1%, revenue growth 41.2% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $502.73M |
| Revenue (TTM) | $0.6B |
| Net Margin | -12.1% |
| Operating Margin (TTM) | -3.6% |
| Net Debt / EBITDA | -2.4 |
| Revenue Growth (YoY) | 41.2% |
| EPS Growth (YoY) | -90.5% |
| FCF Growth (YoY) | -38.7% |
| Price / Sales | 0.86 |
| FCF Yield | -5.6% |
| Altman Z-Score | 2.01 (grey) |
| Industry P/E (Healthcare Services) | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
TOI overview · TOI earnings · TOI KPIs · TOI documents · TOI ownership · TOI peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.